The Sertoli cell: Novel clinical potentiality

The Sertoli cell is important for endocrine and paracrine control of spermatogenesis. Functions attributed to Sertoli cells are: (1) supportive and trophic functions for the cells of the seminiferous epithelium, (2) transport of mature spermatids towards the lumen of seminiferous tubules, (3) secretion of androgen binding protein, (4) production of substances with endocrine or paracrine action for spermatogenesis control and (5) interaction with intertubular endocrine Leydig cells. Inhibin B and anti-Müllerian hormone (AMH) are glycoproteins belonging to the transforming growth factor β (TGF-β) superfamily; they are produced almost exclusively by the Sertoli cells and have been proposed as direct markers of their function and indirect markers of spermatogenesis. Serum inhibin B and AMH concentrations seem to constitute additional diagnostic parameters in male subfertility as they reflect Sertoli cell function. Stimulated concentrations of serum inhibin B and AMH do not add clinically relevant information in subfertile men compared to basal concentrations of these hormones. Serum inhibin B and AMH concentrations correlate with testicular histology/cytology but are not superior to FSH as predictors of the presence of sperm in testicular sperm extraction (TESE)/fine needle aspiration (FNA) biopsy in men with azoospermia.

[1]  D. Goulis,et al.  Dynamic endocrine test of inhibin B and anti-Müllerian hormone in men with non-obstructive azoospermia , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[2]  D. Goulis,et al.  Inhibin B and anti-Mullerian hormone as markers of persistent spermatogenesis in men with non-obstructive azoospermia: a meta-analysis of diagnostic accuracy studies. , 2010, Human reproduction update.

[3]  J. Visser,et al.  Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. , 2009, Fertility and sterility.

[4]  D. Goulis,et al.  Serum inhibin B and anti-Müllerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoospermia. , 2009, Fertility and sterility.

[5]  J. Tostain,et al.  Significance of inhibin B and anti-Müllerian hormone in seminal plasma: a preliminary study. , 2008, Fertility and sterility.

[6]  D. Goulis,et al.  Serum anti-Müllerian hormone levels differentiate control from subfertile men but not men with different causes of subfertility , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  S. Muttukrishna,et al.  Serum anti-Müllerian hormone and inhibin B in disorders of spermatogenesis. , 2007, Fertility and sterility.

[8]  S. Bhasin Approach to the infertile man. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  M. Amer,et al.  Seminal plasma anti-Müllerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE). , 2007, Asian journal of andrology.

[10]  E. Jauniaux,et al.  Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility. , 2007, Reproductive biomedicine online.

[11]  O. Söder,et al.  The sertoli cell - : A hormonal target and 'super' nurse for germ cells that determines testicular size , 2006 .

[12]  S. Oehninger,et al.  Serum anti-Müllerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia , 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[13]  J. Visser,et al.  Development of a sensitive enzyme immunoassay for anti‐Müllerian hormone and the evaluation of potential clinical applications in males and females , 2005, Clinical endocrinology.

[14]  P. Chanson,et al.  Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  T. K. Jensen,et al.  Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  W. Schulze,et al.  Understanding spermatogenesis is a prerequisite for treatment , 2003, Reproductive biology and endocrinology : RB&E.

[17]  A. Pappa,et al.  Assessment of Sertoli cell functional reserve and its relationship to sperm parameters. , 2003, International journal of andrology.

[18]  A. Burdorf,et al.  Inhibin B: a novel marker of spermatogenesis , 2003, Annals of medicine.

[19]  M. Fujisawa,et al.  The significance of anti-Müllerian hormone concentration in seminal plasma for spermatogenesis. , 2002, Human reproduction.

[20]  C. Foresta,et al.  Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. , 2002, Fertility and sterility.

[21]  E. Nieschlag,et al.  Inhibin B in male reproduction: pathophysiology and clinical relevance. , 2001, European journal of endocrinology.

[22]  P. Donahoe,et al.  Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. , 2001, Endocrine reviews.

[23]  R. Anderson,et al.  Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men. , 2001, International journal of andrology.

[24]  Patrick J. Rowe,et al.  Who Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male , 2000 .

[25]  R. Rey,et al.  Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. , 1999, Human reproduction.

[26]  T. Stijnen,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Serum Inhibin B as a Marker of Spermatogenesis , 2022 .

[27]  T. K. Jensen,et al.  Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. , 1997, The Journal of clinical endocrinology and metabolism.

[28]  Y. Siow,et al.  Andrology: The presence of Müllerian inhibiting substance in human seminal plasma , 1996 .

[29]  A. Mcneilly,et al.  Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. , 1996, The Journal of clinical endocrinology and metabolism.

[30]  A. Mcneilly,et al.  Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. , 1996, The Journal of clinical endocrinology and metabolism.

[31]  P. Donahoe,et al.  Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. , 1996, The Journal of clinical endocrinology and metabolism.

[32]  Y. Siow,et al.  The presence of müllerian inhibiting substance in human seminal plasma. , 1996, Human reproduction.

[33]  P. Donahoe,et al.  Mullerian inhibiting substance: a gonadal hormone with multiple functions. , 1993, Endocrine reviews.